Navigation Links
Over 30 New Studies of Oral Xeloda(R) Featured at the 2008 Gastrointestinal Cancers Symposium
Date:1/24/2008

- U.S. Data Highlights Oral Xeloda versus Standard Infusional Chemotherapy

in Gastroesophageal and Colorectal Cancers -

NUTLEY, N.J., Jan. 24 /PRNewswire/ -- Roche announced today that a total of 33 abstracts involving its oral chemotherapy Xeloda(R) have been accepted for presentation at the 2008 Gastrointestinal Cancers Symposium in Orlando, Fla., from Jan. 25 to 27.

Five poster presentations based on U.S. data offer additional knowledge about Xeloda. Two of these U.S. abstracts compare the safety profile and usage patterns of therapy with oral Xeloda to that of intravenous fluorouracil (5-FU) therapy in gastroesophageal cancer. A second pair of U.S. abstracts evaluates the usage patterns and cost of Xeloda-based regimens against those of 5-FU-based regimens in colon and rectal cancer. The fifth U.S. abstract highlights preclinical efficacy and tolerability results of a novel Xeloda regimen (7/7, or 7 days on, 7 days off) using higher daily doses for the treatment of colorectal cancer.
-- Jan. 25, noon to 1 p.m., [Poster No. 72], A claims database analysis of

capecitabine treatment patterns in patients with gastroesophageal

cancer (GEC) (Presenter: Wasif Saif)

-- Jan. 25, noon to 1 p.m., [Poster No. 71], Capecitabine in patients with

gastroesophageal cancer (GEC): A claims database analysis of adverse

events (AEs) (Presenter: Wasif Saif)

-- Jan. 26, 5:30 to 6:30 p.m., [Poster No. 364], A claims database cost-

comparison analysis of capecitabine in the treatment of patients with

colon or rectal cancer (CRC) (Presenter: Edward Chu)

-- Jan. 27, 7 to 8 a.m., [Poster No. 465], Capecitabine use in patients

with colon and rectal cancer (CRC): A claims database analysis of

treatment (Presenter: Edward Chu)

-- Jan. 27, 7 to 8 a.m., [Poster No. A29], In vivo activity of traditional

vs. novel regimens of capecitabine (C) alon
'/>"/>

SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cerimon Pharmaceuticals Initiates Phase II/III Clinical Studies to Evaluate its Diclofenac Patch for Mild to Moderate Pain
2. Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase III Wrinkle and Phase II Full Face Studies
3. GlaxoSmithKline and Theravance Announce Start of Large Phase 2B ICS and LABA Studies for Asthma in the Horizon Program
4. New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies
5. US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium
6. Multiple Studies Presented at San Antonio Breast Cancer Symposium Reinforce Clinical Utility of Oncotype DX(R)
7. Preclinical Studies Show Promise for Novel Antibody Therapy to Treat Acute Myeloid Leukemia (AML)
8. Twelve DOXIL(R) Clinical Studies to be Presented at American Society of Hematology Annual Meeting
9. Genomic Health Announces Eight Oncotype DX(R) Studies to Be Presented at 30th Annual San Antonio Breast Cancer Symposium
10. Senesco Technologies Initiates Preclinical Studies for Cancer Target
11. Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... 2015   NineSigma the leading innovation partner to ... estimated overall revenue growth and anticipates the creation of over ... Open Innovation Incentive (OII). In 2013, the ... of over $2 million to accelerate adoption of open innovation ... and $1 Billion in revenues. To date over 45 middle ...
(Date:8/27/2015)... , Aug. 27, 2015  Generex Biotechnology Corporation ... of a white paper on the status of Generex ... white paper was presented to the August 19, 2015 ... James H. Anderson, Jr. , MD, the Company,s Chief ... on the Generex website. The white paper ...
(Date:8/27/2015)... Calif. , Aug. 27, 2015  Mytrus, a technology and ... software platform for electronic informed consent has received approval ... Health Service (NHS). It is the first time e-Consent ... England . Mytrus was ... use in a clinical trial by the U.S. Food ...
Breaking Medicine Technology:State of Ohio and NineSigma Collaborate to Drive Regional Economic Growth and Job Creation 2State of Ohio and NineSigma Collaborate to Drive Regional Economic Growth and Job Creation 3Generex Announces Issuance of Buccal Insulin White Paper 2Generex Announces Issuance of Buccal Insulin White Paper 3Generex Announces Issuance of Buccal Insulin White Paper 4Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 2Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 3Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 4Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 5Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 6Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 7
... Corporation today,announced that it is seeking 510(k) authorization ... use of its FluDetect(R) Avian Influenza Virus,rapid test ... into the,human point-of-care diagnostic marketplace. While it is ... to the human field, it is,actively seeking an ...
... In Children,s DNA, a Hint of a Mutation,s Ancestral ... researchers,seeking to replicate another group,s discovery of an important ... a particular,variant in DNA that may be more helpful ... populations worldwide. The finding suggests that,the gene variant, identified ...
Cached Medicine Technology:Synbiotics Corporation Announces Human Submission for FluDetect(R) 2Gene Hunters Fine-Tune Marker for Common Obesity Gene 2Gene Hunters Fine-Tune Marker for Common Obesity Gene 3
(Date:8/28/2015)... St. Louis, MO (PRWEB) , ... August 28, ... ... defendants in testosterone lawsuits now consolidated as MDL 2545, Testosterone Replacement ... establishment of a cap on the number of custodial files the PSC may ...
(Date:8/28/2015)... ... 28, 2015 , ... A complimentary webinar offered by healthcare consulting and accounting ... proposal to mandate bundled payments through the Comprehensive Care for Joint Replacement ... Comprehensive Care for Joint Replacement,” takes place at 12 noon EDT on Wednesday, September ...
(Date:8/28/2015)... ... ... Super-Sod launched their new website this summer. The new user-friendly site has ... web design. Website users will now have an improved browsing experience on their phones, ... for the monthly turf-tips email, and find a local Super-Sod store all from the ...
(Date:8/28/2015)... ... 2015 , ... Where can successful, well educated, or attractive ... up to help quality singles find dating partners or ideal matches. , ... well educated, or attractive. , It updates profiles under the category of " ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... through health promotion and disease prevention, improving a patient’s quality of life through ... the community, including heart disease, cancer, diabetes, HIV/AIDS, STDs, and others. A Women’s, ...
Breaking Medicine News(10 mins):Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 2Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 3Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 4Health News:PYA Offers Complimentary CCJR Webina — Game On 2Health News:PYA Offers Complimentary CCJR Webina — Game On 3Health News:MillionaireMatchmakerOnline.net Collects and Updates Newest Millionaire and Quality Single Profiles on the Page of Millionaire Matchmaker Online Canada. 2Health News:MillionaireMatchmakerOnline.net Collects and Updates Newest Millionaire and Quality Single Profiles on the Page of Millionaire Matchmaker Online Canada. 3Health News:Health Clinic Opening and Public Art Unveiling 2
... non-cancerous breast disease, study finds , MONDAY, April 12 (HealthDay ... the chances that they will develop non-cancerous breast disease in ... Research published online April 12 in the journal Pediatrics ... their teen years -- daily or nearly every day -- ...
... to support the fact that smoking in cars is 23 ... analysis article in CMAJ ( Canadian Medical Association ... article, by Australian researchers, describes how a local media report ... times more toxic in a vehicle than in a home"" ...
... of air pollutants, especially nitrogen dioxide, has been associated ... in vitro fertilization, according to a team of fertility ... the first pregnancy attempt of 7,403 women undergoing IVF ... Pa.; Shady Grove Fertility, Rockville, Md.; and Columbia University ...
... Girls and young women who drink alcohol increase their ... by researchers at Washington University School of Medicine in ... the risk for developing breast cancer. "Our study ... increased with the amount of alcohol consumed in this ...
... COLUMBUS, Ohio Most women scheduled for gynecologic surgery to ... they were not worried about the effects of the procedure ... of women planning to be sterilized did express concern in ... the operation even though that surgery does not affect ...
... ... helps women improve body image and boost confidence in time for summer with laser hair ... ... many women, spring ushers in the season of renewed commitment to diet and exercise in ...
Cached Medicine News:Health News:Teen Drinking May Boost Breast Problems Later 2Health News:Teen Drinking May Boost Breast Problems Later 3Health News:Second-hand smoke toxicity in cars: Myth into fact 2Health News:Exposure to nitrogen dioxide lowers in vitro fertilization success 2Health News:Adolescent drinking adds to risk of breast disease, breast cancer 2Health News:Most women facing gynecologic surgery don't worry about its effects on sex 2Health News:Most women facing gynecologic surgery don't worry about its effects on sex 3Health News:Most women facing gynecologic surgery don't worry about its effects on sex 4Health News:Epione Helps Women Get Ready for Bikini Season without Hitting the Gym 2Health News:Epione Helps Women Get Ready for Bikini Season without Hitting the Gym 3
Open wire loops decrease the chance of interfering with instruments, Designed to retract the eyelid during ophthalmic microsurgery or minor office procedures...
Blunt, round tip facilitates easier separation of the nucleus. 45 6.0mm from tip, Blunt, Angled, 6.0mm from tip, 1.5mm from end...
Unique 2 in 1 design allows simultaneous absorption of excess fluid & protection of flap & hinge, Lint-free PVAmaterial....
Smaller diameter wire probes & olive shape tips provide easier insertion through the lacrimal sac, 35cm (14 in) long, ID- .30mm (.012in); OD- .64mm (.025 in). S.S. Probes: .40mm x 11cm (27 G x 4 1/4...
Medicine Products: